The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.Isr J Med Sci. 1977 Jul; 13(7):710-5.IJ
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
270474
Citation
Rachmilewitz, B, and M Rachmilewitz. "The Clinical Significance of Serum Transcobalamins in Myeloid Leukemia and Other Myeloproliferative Disorders." Israel Journal of Medical Sciences, vol. 13, no. 7, 1977, pp. 710-5.
Rachmilewitz B, Rachmilewitz M. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders. Isr J Med Sci. 1977;13(7):710-5.
Rachmilewitz, B., & Rachmilewitz, M. (1977). The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders. Israel Journal of Medical Sciences, 13(7), 710-5.
Rachmilewitz B, Rachmilewitz M. The Clinical Significance of Serum Transcobalamins in Myeloid Leukemia and Other Myeloproliferative Disorders. Isr J Med Sci. 1977;13(7):710-5. PubMed PMID: 270474.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.
AU - Rachmilewitz,B,
AU - Rachmilewitz,M,
PY - 1977/7/1/pubmed
PY - 1977/7/1/medline
PY - 1977/7/1/entrez
SP - 710
EP - 5
JF - Israel journal of medical sciences
JO - Isr J Med Sci
VL - 13
IS - 7
SN - 0021-2180
UR - https://www.unboundmedicine.com/medline/citation/270474/The_clinical_significance_of_serum_transcobalamins_in_myeloid_leukemia_and_other_myeloproliferative_disorders_
L2 - https://www.diseaseinfosearch.org/result/4195
DB - PRIME
DP - Unbound Medicine
ER -